L2: Update COMM
我们是谁
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors
Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors
Phase I/II Trial of the Combination of Bintrafusp Alfa (M7824), Entinostat and NHS-IL12 (M9241) in Patients With Advanced Cancer
Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC
利用 CRISPR 基因工程抑制编码细胞内免疫检查点 CISH 基因的肿瘤浸润淋巴细胞治疗转移性胃肠癌的研究
Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer
对间皮素阳性多发性实体瘤患者进行的 CRISPR-Cas9 介导的 PD-1 和 TCR 基因敲除间皮素定向 CAR-T 细胞研究。
表达 T 细胞受体 (TCR) 的自体 T 细胞对实体瘤受试者的 I/II 期研究
Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer
